ALABRE Trademark

Trademark Overview

On Wednesday, November 30, 2011, a trademark application was filed for ALABRE with the United States Patent and Trademark Office. The USPTO has given the ALABRE trademark a serial number of 85483736. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 9, 2015. This trademark is owned by Glaxo Group Limited. The ALABRE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
alabre

General Information

Serial Number85483736
Word MarkALABRE
Filing DateWednesday, November 30, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 9, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 5, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, November 9, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 9, 2015ABANDONMENT - NO USE STATEMENT FILED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2015EXTENSION 5 GRANTED
Friday, March 27, 2015EXTENSION 5 FILED
Friday, March 27, 2015TEAS EXTENSION RECEIVED
Wednesday, October 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 7, 2014EXTENSION 4 GRANTED
Tuesday, September 30, 2014EXTENSION 4 FILED
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 7, 2014EXTENSION 3 GRANTED
Tuesday, April 1, 2014EXTENSION 3 FILED
Tuesday, April 1, 2014TEAS EXTENSION RECEIVED
Tuesday, October 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2013EXTENSION 2 GRANTED
Wednesday, September 18, 2013EXTENSION 2 FILED
Wednesday, October 23, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 18, 2013TEAS EXTENSION RECEIVED
Tuesday, April 2, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 29, 2013EXTENSION 1 GRANTED
Friday, March 29, 2013EXTENSION 1 FILED
Friday, March 29, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 9, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 24, 2012EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, May 7, 2012EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 6, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 6, 2012ASSIGNED TO LIE
Wednesday, February 15, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 11, 2012ASSIGNED TO EXAMINER
Monday, December 5, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 3, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

alabre pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological